ISI Group Initiates Core Laboratories With Buy
Analysts at ISI Group initiated coverage on Core Laboratories N.V. (NYSE: CLB) with a Buy rating.
The target price for Core Laboratories is set to $151.
Core Laboratories shares have declined 27.02% over the past 52 weeks, while the S&P 500 index has surged 7.46% in the same period.
Core Laboratories' shares gained 3.63% to close at $138.56 yesterday.
Latest Ratings for CLB
Date | Firm | Action | From | To |
---|---|---|---|---|
Jan 2022 | Morgan Stanley | Maintains | Equal-Weight | |
Dec 2021 | Morgan Stanley | Maintains | Equal-Weight | |
Oct 2021 | B of A Securities | Downgrades | Neutral | Underperform |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: ISI GroupInitiation Analyst Ratings